Retinal Imaging in Patients With Inherited Retinal Degenerations
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT00254605
- Status
- Recruiting
Conditions
- Retinitis Pigmentosa
Eligibility Criteria
- Sex
- ALL
- Age
- 13 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
The purpose of this study is to determine whether the structure and function of the human retina can be studied with high resolution in patients with inherited retinal degenerations using the Adaptive Optics Scanning Laser Ophthalmoscope (AOSLO).
Key Dates
- Start date
- Nov 1, 2005
- Status verified
- Jun 2026
- Primary completion
- Oct 1, 2028
- Completion
- Nov 1, 2028
Study Design
- Enrollment
- 400 participants (estimated)
Primary Outcome Measure
Cone spacing [ Time Frame: 24 months ]
Central Contacts
- Jacque L. Duncan, M.D.415-514-4241
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Department of Ophthalmology Retinal Degenerations Clinic, UCSF | San Francisco | California | 94143 |
Find similar trials in San Francisco, CA
Related Studies
- Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic VariantsRecruiting · Jaeb Center for Health Research · Little Rock, Arkansas
- Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal DegenerationRecruiting · Ray Therapeutics, Inc. · Irvine, California
- Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)PHASE2 · Recruiting · jCyte, Inc · Phoenix, Arizona
- Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)Recruiting · Ray Therapeutics, Inc. · Irvine, California